Currently out of the existing stock ratings of John Ransom, 222 are a BUY (90.24%), 2 are a SELL (0.81%), 22 are a HOLD (8.94%).

John Ransom

Work Performance Price Targets & Ratings Chart

Analyst John Ransom, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 66.49% that have a potential upside of 41.51% achieved within 264 days.

John Ransom’s has documented 439 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Consumer Cyclical, Financial Services sectors.

Most recent stock forecast was given on RDNT, RadNet at 05-Mar-2025.

Wall Street Analyst John Ransom

Analyst best performing recommendations are on CANO (CANO HEALTH).
The best stock recommendation documented was for EHC (ENCOMPASS HEALTH CORP) at 2/7/2022. The price target of $63.64 was fulfilled within 8 days with a profit of $5.99 (10.39%) receiving and performance score of 12.99.

Average potential price target upside

of $75.43 (21.33%) on UNH (UNITEDHEALTH GROUP).
of $60.55 (29.82%) on CI (CIGNA CORP).
of $36.31 (18.43%) on HCA (HCA HOLDINGS).

ACHC Acadia Healthcare Company ADUS Addus HomeCare ALHC Alignment Healthcare LLC AMED Amedisys AVAH Aveanna Healthcare Holdings CI Cigna Corp CVET Covetrus CVS CVS Health Corp DVA DaVita HealthCare Partners EHC Encompass Health Corp HCA HCA Holdings HSKA Heska OSH Oak Street Health PHR Phreesia RDNT RadNet THC Tenet Healthcare UNH UnitedHealth Group AGTI Agiliti HCAT Health Catalyst AIRS Airsculpt Technologies PINC Premier SCI Service International CANO Cano Health ACCD Accolade CHNG Change Healthcare TRUP Trupanion GDRX Goodrx Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Ann Hynes (MIZUHO)